These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6124595)

  • 1. Tests for foreign particles in metered-dose aerosols.
    Lea AR; Drew RM; Wong SS; Hailey DM
    J Pharm Pharmacol; 1982 Apr; 34(4):225-9. PubMed ID: 6124595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specification of limits for particulate contamination in pharmaceutical dosage forms.
    Hailey DM; Lea AR; Kendall CE
    J Pharm Pharmacol; 1982 Oct; 34(10):615-20. PubMed ID: 6128382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrostatic charge characteristics of aerosols produced from metered dose inhalers.
    Kwok PC; Glover W; Chan HK
    J Pharm Sci; 2005 Dec; 94(12):2789-99. PubMed ID: 16258995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method of characterizing medicinal drug aerosols generated from pulmonary drug delivery devices.
    Ali M
    PDA J Pharm Sci Technol; 2010; 64(4):364-72. PubMed ID: 21502037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of an aerosol screening model for size-resolved urban aerosols.
    Stanier CO; Lee SR;
    Res Rep Health Eff Inst; 2014 Jun; (179):3-79. PubMed ID: 25145039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of particle size characteristics of metered dose inhaler (MDI) aerosols.
    Dolovich M
    J Aerosol Med; 1991; 4(3):251-63. PubMed ID: 10147682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size analysis of metered suspension pressurized aerosols with the Quantimet 720.
    Hallworth GW; Hamilton RR
    J Pharm Pharmacol; 1976 Dec; 28(12):890-7. PubMed ID: 12265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the Raman spectra and hygroscopicity of four pharmaceutical aerosols as they travel from pressurised metered dose inhalers (pMDI) to a model lung.
    Davidson N; Tong HJ; Kalberer M; Seville PC; Ward AD; Kuimova MK; Pope FD
    Int J Pharm; 2017 Mar; 520(1-2):59-69. PubMed ID: 28159683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter: Contamination of factor-VIII concentrates with metal particles.
    Couper IA; McAdam JH; Mackenzie MJ; Davidson JF
    Lancet; 1974 Dec; 2(7895):1515-6. PubMed ID: 4140427
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the variance components in a pharmaceutical aerosol product: lodoxamide tromethamine.
    Havel HA; Beaubien LJ; Haaland PD
    J Pharm Sci; 1985 Sep; 74(9):978-82. PubMed ID: 4067853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequate expression for average particle size of microbiological aerosols.
    KETHLEY TW; COWN WB; FINCHER EL
    Appl Microbiol; 1963 May; 11(3):188-9. PubMed ID: 14032184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of solution-based pressurised metered-dose inhaler aerosols with an optical particle counter.
    Kuhli M; Weiss M; Steckel H
    Eur J Pharm Biopharm; 2010 Aug; 75(3):393-8. PubMed ID: 20347974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-of-flight aerodynamic particle size analyzers: their use and limitations for the evaluation of medical aerosols.
    Mitchell JP; Nagel MW
    J Aerosol Med; 1999; 12(4):217-40. PubMed ID: 10724637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metrological assessment of a portable analyzer for monitoring the particle size distribution of ultrafine particles.
    Stabile L; Cauda E; Marini S; Buonanno G
    Ann Occup Hyg; 2014 Aug; 58(7):860-76. PubMed ID: 24817159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerodynamic size distribution of metered-dose bronchodilator aerosols.
    Hiller C; Mazumder M; Wilson D; Bone R
    Am Rev Respir Dis; 1978 Aug; 118(2):311-7. PubMed ID: 697181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
    Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
    Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on particle contamination produced by syringe needles and rubber stoppers for pharmaceutical solutions].
    Zhao L; Wang HS; Han ZF
    Zhonghua Hu Li Za Zhi; 1997 Jan; 32(1):12-4. PubMed ID: 9304949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.